Cargando…
Anti-Tumor Effect of Apatinib and Relevant Mechanisms in Liposarcoma
BACKGROUND: Primary retroperitoneal liposarcomas (RLPSs) are rare heterogeneous tumors for which there are few effective therapies. Certain anti-angiogenic tyrosine kinase inhibitors have demonstrated efficacy against various solid tumors. The aims of this study were to investigate the effect of Apa...
Autores principales: | Cui, Lixuan, Yan, Liang, Guan, Xiaoya, Dong, Bin, Zhao, Min, Lv, Ang, Liu, Daoning, Wang, Zhen, Liu, Faqiang, Wu, Jianhui, Tian, Xiuyun, Hao, Chunyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637299/ https://www.ncbi.nlm.nih.gov/pubmed/34868934 http://dx.doi.org/10.3389/fonc.2021.739139 |
Ejemplares similares
-
Tsp2 Facilitates Tumor-associated Fibroblasts Formation and Promotes Tumor Progression in Retroperitoneal Liposarcoma
por: Xu, Chang, et al.
Publicado: (2022) -
Establishment and evaluation of retroperitoneal liposarcoma patient-derived xenograft models: an ideal model for preclinical study
por: Xu, Chang, et al.
Publicado: (2022) -
Expression and function of Siglec-15 in RLPS and its correlation with PD-L1: Bioinformatics Analysis and Clinicopathological Evidence
por: Cui, Lixuan, et al.
Publicado: (2022) -
Identification of the γ-glutamyl cycle as a novel therapeutic target and 5-oxoproline as a new biomarker for diagnosing pancreatic cancer
por: Wang, Weijia, et al.
Publicado: (2023) -
Comprehensive immune characterization and T‐cell receptor repertoire heterogeneity of retroperitoneal liposarcoma
por: Yan, Liang, et al.
Publicado: (2019)